170 related articles for article (PubMed ID: 31398615)
1. A new GSH-responsive prodrug of 5-aminolevulinic acid for photodiagnosis and photodynamic therapy of tumors.
Li K; Dong W; Qiu L; Liu Q; Lv G; Peng Y; Xie M; Lin J
Eur J Med Chem; 2019 Nov; 181():111582. PubMed ID: 31398615
[TBL] [Abstract][Full Text] [Related]
2. Dual-targeted 5-aminolevulinic acid derivatives with glutathione depletion function for enhanced photodynamic therapy.
Li K; Dong W; Miao Y; Liu Q; Qiu L; Lin J
J Photochem Photobiol B; 2021 Feb; 215():112107. PubMed ID: 33401190
[TBL] [Abstract][Full Text] [Related]
3. Design of Bifunctional Dendritic 5-Aminolevulinic Acid and Hydroxypyridinone Conjugates for Photodynamic Therapy.
Zhou T; Battah S; Mazzacuva F; Hider RC; Dobbin P; MacRobert AJ
Bioconjug Chem; 2018 Oct; 29(10):3411-3428. PubMed ID: 30249090
[TBL] [Abstract][Full Text] [Related]
4. Enhancing selective photosensitizer accumulation and oxygen supply for high-efficacy photodynamic therapy toward glioma by 5-aminolevulinic acid loaded nanoplatform.
Wang X; Tian Y; Liao X; Tang Y; Ni Q; Sun J; Zhao Y; Zhang J; Teng Z; Lu G
J Colloid Interface Sci; 2020 Apr; 565():483-493. PubMed ID: 31982715
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates.
Zhang J; Yuan S; Fan M; Wang K; Guo J; Zang A; Ren J; Su W; Zhang C; Xie Y
Bioorg Med Chem; 2024 May; 105():117726. PubMed ID: 38626642
[TBL] [Abstract][Full Text] [Related]
6. Modulating ALA-PDT efficacy of mutlidrug resistant MCF-7 breast cancer cells using ALA prodrug.
Feuerstein T; Berkovitch-Luria G; Nudelman A; Rephaeli A; Malik Z
Photochem Photobiol Sci; 2011 Dec; 10(12):1926-33. PubMed ID: 22020364
[TBL] [Abstract][Full Text] [Related]
7. Activity of phosphatase-sensitive 5-aminolevulinic acid prodrugs in cancer cell lines.
Herceg V; Lange N; Allémann E; Babič A
J Photochem Photobiol B; 2017 Jun; 171():34-42. PubMed ID: 28472723
[TBL] [Abstract][Full Text] [Related]
8. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
[TBL] [Abstract][Full Text] [Related]
9. Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.
Yang X; Palasuberniam P; Myers KA; Wang C; Chen B
Oncotarget; 2016 Sep; 7(36):57798-57810. PubMed ID: 27527860
[TBL] [Abstract][Full Text] [Related]
10. Glycoside esters of 5-aminolevulinic acid for photodynamic therapy of cancer.
Vallinayagam R; Schmitt F; Barge J; Wagnieres G; Wenger V; Neier R; Juillerat-Jeanneret L
Bioconjug Chem; 2008 Apr; 19(4):821-39. PubMed ID: 18341270
[TBL] [Abstract][Full Text] [Related]
11. 5-Aminolevulinic acid-based photodynamic therapy of chordoma: In vitro experiments on a human tumor cell line.
Cornelius JF; Eismann L; Ebbert L; Senger B; Petridis AK; Kamp MA; Sorg RV; Steiger HJ
Photodiagnosis Photodyn Ther; 2017 Dec; 20():111-115. PubMed ID: 28951177
[TBL] [Abstract][Full Text] [Related]
12. Systemic MEK inhibition enhances the efficacy of 5-aminolevulinic acid-photodynamic therapy.
Chelakkot VS; Som J; Yoshioka E; Rice CP; Rutihinda SG; Hirasawa K
Br J Cancer; 2019 Oct; 121(9):758-767. PubMed ID: 31551581
[TBL] [Abstract][Full Text] [Related]
13. Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy.
Johnson RP; Chung CW; Jeong YI; Kang DH; Suh H; Kim I
Int J Nanomedicine; 2012; 7():2497-512. PubMed ID: 22679363
[TBL] [Abstract][Full Text] [Related]
14. [5-Aminolevulinic acid esters based photodynamic therapy].
Zhang S; Zhang Z; Jiang D
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jun; 19(2):310-4. PubMed ID: 12224308
[TBL] [Abstract][Full Text] [Related]
15. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin.
Kloek J; Akkermans W; Beijersbergen van Henegouwen GM
Photochem Photobiol; 1998 Jan; 67(1):150-4. PubMed ID: 9477773
[TBL] [Abstract][Full Text] [Related]
16. Zwitterionic stealth peptide-capped 5-aminolevulinic acid prodrug nanoparticles for targeted photodynamic therapy.
Wu J; Lin Y; Li H; Jin Q; Ji J
J Colloid Interface Sci; 2017 Jan; 485():251-259. PubMed ID: 27676086
[TBL] [Abstract][Full Text] [Related]
17. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of new 5-aminolevulinic acid derivatives as prodrugs of protoporphyrin for photodynamic therapy.
Zhu W; Gao YH; Song CH; Lu ZB; Namulinda T; Han YP; Yan YJ; Wang LX; Chen ZL
Photochem Photobiol Sci; 2017 Nov; 16(11):1623-1630. PubMed ID: 28933502
[TBL] [Abstract][Full Text] [Related]
19. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminolaevulinic acid peptide prodrugs enhance photosensitization for photodynamic therapy.
Bourré L; Giuntini F; Eggleston IM; Wilson M; MacRobert AJ
Mol Cancer Ther; 2008 Jun; 7(6):1720-9. PubMed ID: 18566243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]